Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 1Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Hepatocellular 9Papillomavirus Infections 4Lymphoma, Non-Hodgkin 4Hypertension, Portal 4Febrile Neutropenia 4Carcinoma, Non-Small-Cell Lung 4Polycystic Ovary Syndrome 3Ovarian Cysts 3Multiple Myeloma 3Lung Neoplasms 3Cancer Pain 3Adenomatous Polyposis Coli 3Recurrence 2Rectal Neoplasms 2Prostatic Hyperplasia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Neoplasms 2Lymphoma, B-Cell 2Lymphoma 2Liver Cirrhosis 2Leiomyoma 2Infertility 2Hyperthermia 2Hematologic Neoplasms 2Esophageal Neoplasms 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Surgical Wound Infection 1

Interventions

endostar protein 1Pemetrexed 1Endostatins 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × OTHER_GOV × Adenocarcinoma of Lung × Clear all
NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Anhui Provincial Hospital

Phase 4 Unknown
100 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡